SMAC mimetic Debio 1143 synergizes with taxanes, topoisomerase inhibitors and bromodomain inhibitors to impede growth of lung adenocarcinoma cells

Documenti analoghi

• The inhibitor apoptosis protein antagonist Debio 1143 Is an attractive HIV-1 latency reversal candidate
  di: Bobardt, Michael, et al.
  Pubblicazione: (2019)
• The inhibitor of apoptosis proteins antagonist Debio 1143 promotes the PD-1 blockade-mediated HIV load reduction in blood and tissues of humanized mice
  di: Bobardt, Michael, et al.
  Pubblicazione: (2020)
• DEBIO 1143, an IAP inhibitor, reverses carboplatin resistance in ovarian cancer cells and triggers apoptotic or necroptotic cell death
  di: Thibault, Benoît, et al.
  Pubblicazione: (2018)
• Debio 1143, an antagonist of multiple inhibitor-of-apoptosis proteins, activates apoptosis and enhances radiosensitization of non-small cell lung cancer cells in vitro
  di: Liu, Ningbo, et al.
  Pubblicazione: (2014)
• Combinatorial Screening of Pancreatic Adenocarcinoma Reveals Sensitivity to Drug Combinations Including Bromodomain Inhibitor plus Neddylation Inhibitor
  di: Langdon, Casey G., et al.
  Pubblicazione: (2017)